Accès ouvert
2026
article
OpenAlex
Salma N. Annisa, Almira Alifia, Alamanda Larasmanah, Nurlaila S. Ramadhani et autres
OBJECTIVES: Targeted next-generation sequencing (tNGS) offers promise in the rapid detection of drug-resistant tuberculosis (DR-TB) directly from sputum. While pilot studies on tNGS are emerging, there is limited empirical qualitative evidence on tNGS implementation. This study, therefore, aimed to explore the experiences …
id, nl, gb, nz
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Prayudi Santoso, Alya Putri Khairani, Eppy Buchori Aristiady, Lidya Chaidir et autres
Objectives: The increasing incidence of primary multidrug-resistant tuberculosis (MDR-TB) creates a new burden in national tuberculosis (TB) control. Understanding the characteristics of primary MDR-TB aids in predicting its spread. This study aimed to determine the differences in characteristics of primary and acquired …
id
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Bony Wiem Lestari, Silvi Indriani, Adriana Viola Miranda, Dyah Ayu Nur Safira et autres
BACKGROUND: People with drug-resistant tuberculosis (DR-TB) experience multiple visits to healthcare providers before DR-TB diagnosis and treatment. Our study aimed to quantify pretreatment direct costs and factors associated with higher costs among people with DR-TB. METHODS: Our cross-sectional study aimed to recruit …
id
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Bony Wiem Lestari, Rifky Waluyajati Rachman, Rahmah Aulia Zahra, Alamanda Larasmanah et autres
Background: The availability of targeted Next Generation Sequencing (tNGS) for drug-resistant tuberculosis (DRTB) is a major advance in TB diagnostics, but its optimal implementation, yield, and cost in high TB-incidence settings remain unclear. We aimed to evaluate tNGS in relation to laboratory …
id, nz, nl, gb
(code pays fourni par la source)
Accès ouvert
2026
dissertation
OpenAlex
Chrispian Mamudi, Purnamawati -, Panca Andana, Prayudi Santoso et autres
Tuberculosis (TB) remains a leading cause of infectious mortality worldwide, reflecting persistent gaps in diagnosis, risk stratification, and treatment monitoring. Host RNA transcriptomic signatures have emerged as promising tools for capturing dynamic immune responses across the TB disease spectrum. Among these, the …
id
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Arto Yuwono Soeroto, Aga Purwiga, Hendarsyah Suryadinata, Bachti Alisjahbana et autres
BACKGROUND AND AIMS: Drug-resistant tuberculosis (DR-TB) poses a serious challenge in Indonesia, with treatment success rates of only 50%. The BPaLM/BPaL regimen represents the latest therapeutic approach, offering shorter duration, minimal side effects, and treatment success rates of 84-90%. An operational research …
id
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Chrispian Mamudi, Arto Yuwono Soeroto, Lidya Chaidir, Purnamawati - et autres
Tuberculosis (TB) remains a leading cause of infectious mortality worldwide, reflecting persistent gaps in diagnosis, risk stratification, and treatment monitoring. Host RNA transcriptomic signatures have emerged as promising tools for capturing dynamic im-mune responses across the TB disease spectrum. Among these, the …
id
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Bony Wiem Lestari, Rifky Waluyajati Rachman, Rahmah Aulia Zahra, Alamanda Larasmanah et autres
id, nz, nl
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Husneni Mukhtar, Bony Wiem Lestari, Nabila Nur Fadilah Hidayat, Sonya Alexandra et autres
id
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Intan Mauli Warma Dewi, Raden Nabilah Putri Fauziyyah, Iceu Dimas Kulsum, Bony Wiem Lestari et autres
Background: Tuberculosis (TB) affects over 10 million people worldwide and causes more than 1.4 million deaths in 2019. Despite improvements in TB treatment, many TB survivors experience ongoing health problems. Post-TB lung disease (PTLD) affects 30-60% of treated patients, leading to chronic …
id
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Htin Lin Aung, Lidya Chaidir, Dian Ayu Eka Pitaloka, Narender Kumar et autres
OBJECTIVE: This study evaluated drug resistance profiles of Mycobacterium tuberculosis (Mtb) isolates in West Java, Indonesia through phenotypic and genomic approaches. METHODS: We performed phenotypic drug-susceptibility testing (DST), coupled with whole-genome sequencing (WGS) of 142 Mtb isolates identified as RIF-R (Rifampicin resistant) …
nz, id, gb, nl
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Lara D Veeken, Iceu Dimas Kulsum, Bony Wiem Lestari, Prayudi Santoso et autres
Abstract Background Diabetes is a risk factor for mortality during rifampicin-resistant tuberculosis (RR-TB) treatment, but whether its impact differs by nutritional status is unknown. We estimated the effect of diabetes and its interaction with low body mass index (BMI) (ie, <18.5 kg/m2) …
nl, us, id, kh, gb
(code pays fourni par la source)